Aminobenzoic acid tablets

Its stereo configuration is similar to that of lysine, and it can competitively inhibit the adsorption of plasminogen on the fibrin network, protecting the fibrin from being degraded by plasmin and achieving a hemostatic effect.

The main ingredient of this product and its chemical name is: aminomethylbenzoic acid.

This product is white or off-white tablets.

It is suitable for various bleeding caused by hyperactivity of fibrinase, such as abnormal bleeding during surgery and obstetrics and gynecology, and can also be used for purpura, leukemia, hemoptysis caused by tuberculosis, etc. It has a significant hemostatic effect on oozing blood. It has no hemostatic effect on severe hemorrhage (trauma, cancer, etc.). It can also be used for bleeding caused by excessive streptokinase or urokinase.

Oral administration: 0.25~0.5g each time, 2~3 times a day, total daily amount is 2g.

Long-term use may promote thrombosis. Occasionally dizziness, headache, and abdominal discomfort may occur.

It should not be used or should be used with caution by patients with thrombosis tendency and embolic diseases.

Precautions for children: Not yet clear. Precautions for pregnancy and lactation: Not yet clear. Precautions for the elderly: Not yet clear.

The combined use of oral contraceptives or estrogens with this product may increase the risk of thrombosis.

Keep sealed.

0.25g

24 months

Gansu Lanyao Pharmaceutical Co., Ltd.

• Founded in:

  2006-12-22

• Address:

  No. 1739, Middle Section of Kunlunshan Avenue, Lanzhou New District, Lanzhou City, Gansu Province

• Tax NO.:

  916200007948829218

• Registered Funds:

  84.5 million yuan

• Email:

  Log in to view